Jekkie Kim is a corporate associate in Latham & Watkins' Silicon Valley office. Dr. Kim advises clients in the healthcare and life sciences space including biotech, medical device, and pharmaceutical companies on strategic licensing and collaborations, tech transfer, complex commercial agreements, venture financing, M&A, and corporate governance.
Dr. Kim has extensive experience working with digital health companies on creative solutions to complex, fast-paced, often disruptive legal issues that require a multidisciplinary approach.
She advises clients on matters such as:
- Licensing transactions
- M&A
- Profit-sharing agreements
- Co-promotion arrangements
- Other complex commercial transactions
Dr. Kim represented life sciences clients for five years in Boston prior to relocating to Silicon Valley. In Boston, she was also a member of the Institutional Review Board (IRB) at Massachusetts General Hospital (MGH).
She was trained as an intern physician at Seoul National University Hospital and practiced as a primary care physician for over two years thereafter prior to attending law school. She is currently actively licensed as a physician in Korea.
In Cleveland, Dr. Kim worked for BioEnterprise, a business formation, recruitment, and acceleration initiative designed to grow healthcare companies and commercialize bioscience technologies in Ohio. There, as a business associate, she assisted with potential investment target diligence and commercialization efforts of portfolio companies.
Dr. Kim maintains an active pro bono practice, advising clients across a spectrum of issues. Her recent work includes advising clients of an eviction clinic, and a non-profit that has developed a tool that diagnoses children who have experienced adverse toxic events.